Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 11 studies | 26% ± 14% | |
plasmablast | 6 studies | 35% ± 19% | |
CD4-positive, alpha-beta T cell | 5 studies | 29% ± 6% | |
natural killer cell | 4 studies | 23% ± 4% | |
CD8-positive, alpha-beta T cell | 4 studies | 24% ± 6% | |
epithelial cell | 3 studies | 18% ± 2% | |
T cell | 3 studies | 26% ± 6% | |
dendritic cell | 3 studies | 33% ± 8% |
Insufficient scRNA-seq data for expression of PHF19 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1751.05 | 2639 / 2642 | 100% | 38.96 | 705 / 705 |
uterus | 100% | 3781.11 | 170 / 170 | 100% | 28.56 | 457 / 459 |
esophagus | 100% | 3527.23 | 1445 / 1445 | 99% | 20.47 | 182 / 183 |
skin | 99% | 1774.08 | 1796 / 1809 | 100% | 34.27 | 472 / 472 |
lung | 100% | 2364.98 | 577 / 578 | 99% | 16.64 | 1145 / 1155 |
intestine | 100% | 2750.52 | 963 / 966 | 99% | 25.07 | 523 / 527 |
ovary | 100% | 3815.68 | 180 / 180 | 98% | 15.41 | 421 / 430 |
breast | 100% | 1911.80 | 459 / 459 | 98% | 14.28 | 1091 / 1118 |
adrenal gland | 100% | 1572.15 | 258 / 258 | 96% | 16.34 | 221 / 230 |
thymus | 100% | 1534.87 | 651 / 653 | 96% | 13.16 | 583 / 605 |
prostate | 100% | 3227.72 | 245 / 245 | 96% | 9.33 | 480 / 502 |
bladder | 100% | 3758.90 | 21 / 21 | 92% | 19.64 | 466 / 504 |
stomach | 91% | 2036.29 | 325 / 359 | 100% | 21.91 | 285 / 286 |
kidney | 83% | 947.71 | 74 / 89 | 81% | 7.66 | 727 / 901 |
pancreas | 24% | 160.04 | 80 / 328 | 98% | 12.80 | 174 / 178 |
blood vessel | 100% | 3992.90 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 53.72 | 29 / 29 |
spleen | 100% | 2761.18 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.34 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.25 | 1 / 1 |
adipose | 100% | 2030.22 | 1203 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 10.69 | 79 / 80 |
peripheral blood | 97% | 3124.77 | 905 / 929 | 0% | 0 | 0 / 0 |
heart | 96% | 1260.28 | 828 / 861 | 0% | 0 | 0 / 0 |
muscle | 88% | 720.03 | 708 / 803 | 0% | 0 | 0 / 0 |
liver | 22% | 163.19 | 50 / 226 | 53% | 5.27 | 217 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045814 | Biological process | negative regulation of gene expression, epigenetic |
GO_0048863 | Biological process | stem cell differentiation |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0035098 | Cellular component | ESC/E(Z) complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0035064 | Molecular function | methylated histone binding |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | PHF19 |
Protein name | PHD finger protein 19 (Polycomb-like protein 3) (hPCL3) PHD finger protein 19 |
Synonyms | PCL3 |
Description | FUNCTION: Polycomb group (PcG) protein that specifically binds histone H3 trimethylated at 'Lys-36' (H3K36me3) and recruits the PRC2 complex, thus enhancing PRC2 H3K27me3 methylation activity . Probably involved in the transition from an active state to a repressed state in embryonic stem cells: acts by binding to H3K36me3, a mark for transcriptional activation, and recruiting H3K36me3 histone demethylases RIOX1 or KDM2B, leading to demethylation of H3K36 and recruitment of the PRC2 complex that mediates H3K27me3 methylation, followed by de novo silencing . Recruits the PRC2 complex to CpG islands and contributes to embryonic stem cell self-renewal. Also binds histone H3 dimethylated at 'Lys-36' (H3K36me2) . Isoform 1 and isoform 2 inhibit transcription from an HSV-tk promoter . . |
Accessions | ENST00000616568.5 ENST00000436309.5 ENST00000456291.1 A0A087X169 ENST00000312189.10 [Q5T6S3-2] ENST00000453868.5 ENST00000439674.1 ENST00000419155.5 B0QZ51 B0QZ72 Q5T6S3 ENST00000373896.8 [Q5T6S3-1] F5H8K3 B0QZ50 X6RER8 |